KENTARO IDE

Last Updated :2020/09/15

Affiliations, Positions
Hiroshima University Hospital(Medical), Associate Professor or Lecturer
E-mail
idekenhiroshima-u.ac.jp

Basic Information

Major Professional Backgrounds

  • 2008/03/01, 2008/08/31, Hiroshima University Hospital, Clinical Fellow
  • 2008/09/01, 2019/04/30, Hiroshima University Hospital, Assistant Professor
  • 2014/04/01, Hiroshima University, Lecturer
  • 2019/05/01, Hiroshima University, Hospital, Lecturer

Educational Backgrounds

  • Hiroshima University, Japan, 2003/04, 2007/03
  • Hiroshima University, Japan, 1991/04, 1997/03

Academic Degrees

  • Doctor of Philosophy in Medical Science, Hiroshima University

Educational Activity

  • 【Bachelor Degree Program】School of Medicine : Program of Medicine

In Charge of Primary Major Programs

  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;General surgery

Affiliated Academic Societies

  • Japan Surgical Society
  • The Japanese Society of Gastroenterological Surgery
  • The Japan Society for Transplantation
  • Japanese Society for Clinical Renal Transplantation
  • Japanese Liver Transplantation Society
  • The Japan Society for Organ Preservation and Biology
  • The Japanese Society for Dialysis Therapy
  • Japanese Society of Pathophysiology in Kidney Failure

Educational Activity

Course in Charge

  1. 2020, Undergraduate Education, Intensive, Symptomatology, Diagnosis and Treatment

Research Activities

Academic Papers

  1. A phased desensitization protocol with rituximab and bortezomib for highly sensitized kidney transplant candidates., TRANSPLANTATION DIRECT, 6-15
  2. Fc-gamma receptor 3A polymorphism predicts the incidence of urinary tract infection in kidney-transplant recipients., HUMAN IMMUNOLOGY, 78(4), 357-362, 201704
  3. Different sensitivity of rituximab-treatment to B-cells between ABO-incompatible kidney and liver transplantation, HUMAN IMMUNOLOGY, 77(6), 456-463, JUN 2016
  4. Fc-Gamma Receptor Polymorphisms Predispose Patients to Infectious Complications After Liver Transplantation, AMERICAN JOURNAL OF TRANSPLANTATION, 16(2), 625-633, FEB 2016
  5. Kidney transplantation from an anti-hepatitis C virus antibody-positive donor into an anti-hepatitis C virus antibody-negative recipient: A case report., Transplantation Reports, 1, 4-6, 2016
  6. Successful resolution of very severe hepatopulmonary syndrome following adult-to-adult living donor liver transplantation: Report of two cases, HEPATOLOGY RESEARCH, 45(9), 1041-1046, SEP 2015
  7. Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient, HEPATOLOGY RESEARCH, 45(10), E150-E155, OCT 2015
  8. Intraoperative assessment of tissue oxygen saturation of the remnant stomach by near-infrared spectroscopy in two cases of pancreatectomy following gastrectomy, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 22, 75-78, 2016
  9. Inflammatory pseudotumor of the liver occurring during the course of hepatitis C virus-related hepatocellular carcinoma treatment: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 20, 96-100, 2016
  10. Stepwise approach to curative surgery using percutaneous transhepatic cholangiodrainage and portal vein embolization for severe bile duct injury during laparoscopic cholecystectomy: a case report, SURGICAL CASE REPORTS, 2, MAR 17 2016
  11. Three patients treated with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation: Case report, HEPATOLOGY RESEARCH, 46(7), 707-712, JUN 2016
  12. Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation, HEPATOLOGY RESEARCH, 46(7), 622-633, JUN 2016
  13. Intrahepatic cholangiocarcinoma coinciding with a liver metastasis from a rectal carcinoma: a case report, SURGICAL CASE REPORTS, 2, SEP 9 2016
  14. Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis C: pilot study, JOURNAL OF VIRAL HEPATITIS, 23(11), 850-856, NOV 2016
  15. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients, INTERNATIONAL JOURNAL OF SURGERY, 36, 96-103, DEC 2016
  16. Elective laparoscopic deroofing to treat the spontaneous rupture of a large simple liver cyst: a case report, SURGICAL CASE REPORTS, 2, DEC 7 2016
  17. Predictive Independent Factors for Extrahepatic Metastasis of Hepatocellular Carcinoma Following Curative Hepatectomy, ANTICANCER RESEARCH, 37(5), 2625-2631, 201705
  18. Biliary-duodenal anastomosis using magnetic compression following massive resection of small intestine due to strangulated ileus after living donor liver transplantation: a case report, SURGICAL CASE REPORTS, 3, 20170525
  19. Significance of the Glasgow Prognostic Score for patients with colorectal liver metastasis, INTERNATIONAL JOURNAL OF SURGERY, 42, 209-214, 201706
  20. Central bisectionectomy for hepatocellular carcinoma in a patient with indocyanine green excretory defect associated with reduced expression of the liver transporter., SURGICAL CASE REPORTS, 2(1), 89, 2016
  21. Expression of Recipient CD47 on Rat Insulinoma Cell Xenografts Prevents Macrophage-Mediated Rejection through SIRP alpha Inhibitory Signaling in Mice, PLOS ONE, 8(3), MAR 5 2013
  22. Role for CD47-SIRP alpha signaling in xenograft rejection by macrophages, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 104(12), 5062-5066, MAR 20 2007
  23. Bile CXC Motif Chemokine 10 Levels Correlate With Anti-donor Cytotoxic T Cell Responses After Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 46(3), 790-793, APR 2014
  24. Multiple Hepatic Vein Reconstruction Using an All-in-one Sleeve Patch Graft Technique in Living Donor Liver Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 46(3), 982-985, APR 2014
  25. Risk Factors for Development of New-Onset Diabetes Mellitus and Progressive Impairment of Glucose Metabolism After Living-Donor Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 46(3), 865-869, APR 2014
  26. Clinical Efficacy of Simultaneous Splenectomy in Liver Transplant Recipients With Hepatitis C Virus, TRANSPLANTATION PROCEEDINGS, 46(3), 770-773, APR 2014
  27. Potential Benefit of Mixed Lymphocyte Reaction Assay-based Immune Monitoring After Living Donor Liver Transplantation for Recipients With Autoimmune Hepatitis, TRANSPLANTATION PROCEEDINGS, 46(3), 785-789, APR 2014
  28. Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation, HEPATOLOGY RESEARCH, 44(12), 1259-1264, NOV 2014
  29. Pancreaticoduodenectomy with preservation of gastric tube blood flow after esophagectomy: Report of a case. , INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 5(10), 746-749, 2014
  30. A case of gastric cancer following living donor liver transplantation., HIROSHIMA JOURNAL OF MRDICAL SCIENCES, 63(1), 23-26, 2014
  31. Surgical treatment for portosystemic encephalopathy in patients with liver cirrhosis: Occlusion of portosystemic shunt in combination with splenectomy, HEPATOLOGY RESEARCH, 43(3), 249-254, MAR 2013
  32. Controlling the bleeding of jejunal varices formed at the site of choledochojejunostomy: report of 2 cases and a review of the literature, SURGERY TODAY, 43(5), 550-555, MAY 2013
  33. Attenuation of Portal Hypertension by Continuous Portal Infusion of PGE1 and Immunologic Impact in Adult-to-Adult Living-Donor Liver Transplantation, TRANSPLANTATION, 95(12), 1521-1527, JUN 27 2013
  34. Inferior vena cava tumor thrombus that directly infiltrated from paracaval lymph node metastases in a patient with recurrent hepatocellular carcinoma, WORLD JOURNAL OF SURGICAL ONCOLOGY, 11, AUG 6 2013
  35. Optimization of Immunosuppressive Therapy Based on a Multiparametric Mixed Lymphocyte Reaction Assay Reduces Infectious Complications and Mortality in Living Donor Liver Transplant Recipients, TRANSPLANTATION PROCEEDINGS, 44(2), 555-559, MAR 2012
  36. Complex Vascular Reconstruction Using Donor's Vessel Grafts in Orthotopic Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 44(2), 574-578, MAR 2012
  37. Incidental renal cell carcinoma presenting in a renal transplant recipient with autosomal dominant polycystic kidney disease: a case report., JOURNAL OF MEDICAL CASE REPORT, 13(6), 154, 20120601
  38. Safety and Feasibility of Diet-Treated Donors With Steatotic Livers at the Initial Consultation for Living-Donor Liver Transplantation, TRANSPLANTATION, 93(10), 1024-1030, MAY 27 2012
  39. Renal Vein Extension Using an Autologous Renal Vein in a Living Donor With Double Inferior Vena Cava: A Case Report, TRANSPLANTATION PROCEEDINGS, 44(5), 1446-1449, JUN 2012
  40. Kinetics of Cellular and Humoral Immunity in a Successful Case of Positive Crossmatch Kidney Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 43(6), 2411-2414, JUL-AUG 2011
  41. Long-Term Outcome of Hepatic Artery Reconstruction during Living-Donor Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 43(5), 1720-1724, JUN 2011
  42. Evidence for the immunosuppressive potential of calcineurin inhibitor-sparing regimens in liver transplant recipients with impaired renal function., JOURNAL OF TRANSPLANTATION, 483728, 20110601
  43. Impact of Adjuvant Immunotherapy Using Liver Allograft-Derived Lymphocytes on Bacteremia in Living-Donor Liver Transplantation, TRANSPLANTATION, 92(5), 575-580, SEP 2011
  44. Human CD47 Expression Permits Survival of Porcine Cells in Immunodeficient Mice That Express SIRP alpha Capable of Binding to Human CD47, CELL TRANSPLANTATION, 20(11-12), 1915-1920, 2011
  45. Determination of the precursor frequency and the reaction intensity of xenoreactive human T lymphocytes., XENOTRANSPLANTATION, 17(3), 188-196, 20100501
  46. Immunological Property of Antibodies against N-Glycolylneuraminic Acid Epitopes in Cytidine Monophospho-N-Acetylneuraminic Acid Hydroxylase-Deficient Mice, JOURNAL OF IMMUNOLOGY, 184(6), 3269-3275, MAR 15 2010
  47. Deficiency of N-glycolylneuraminic acid and Gal alpha 1-3Gal beta 1-4GlcNAc epitopes in xenogeneic cells attenuates cytotoxicity of human natural antibodies, XENOTRANSPLANTATION, 17(6), 440-448, NOV-DEC 2010
  48. Significant Correlation Between Spleen Volume and Thrombocytopenia in Liver Transplant Patients: A Concept for Predicting Persistent Thrombocytopenia, LIVER TRANSPLANTATION, 15(2), 208-215, FEB 2009
  49. ABO-blood type incompatible living donor liver transplantation in a patient with Budd-Chiari Syndrome secondary to essential thrombocythemia, HEPATOLOGY RESEARCH, 39(5), 520-524, MAY 2009
  50. Successful hepatitis B vaccination in liver transplant recipients with donor-specific hyporesponsiveness, TRANSPLANT INTERNATIONAL, 22(8), 805-813, AUG 2009
  51. Surgical techniques for prevention of recurrence after total enterolysis in encapsulating peritoneal sclerosis., Adv Perit Dial., 24, 51-55, 20080401
  52. Prophylaxis against recurrence of HBV hepatitis after living-donor liver transplantation., HEPATOGASTROENTEROLOGY, 55(86-87), 1746-1749, 20080901
  53. Recommendation of the surgical option for treatment of encapsulating peritoneal sclerosis., Perit Dial Int., 28, S205-210, 20080601
  54. Possible therapeutic effect of lipid supplementation on neurological complications in liver transplant recipients, TRANSPLANT INTERNATIONAL, 20(7), 632-635, JUL 2007
  55. Microsurgical hepatic artery reconstruction during living-donor liver transplantation by using head-mounted surgical binocular system, TRANSPLANT INTERNATIONAL, 20(11), 970-973, NOV 2007
  56. The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation, BLOOD, 110(13), 4567-4575, DEC 15 2007
  57. Liver sinusoidal endothelial cells that endocytose allogeneic cells suppress T cells with indirect allospecificity, JOURNAL OF IMMUNOLOGY, 177(6), 3615-3624, SEP 15 2006
  58. Antibody- and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells, XENOTRANSPLANTATION, 12(3), 181-188, MAY 2005
  59. Liver sinusoidal endothelial cells tolerize T cells across MHC barriers in mice, JOURNAL OF IMMUNOLOGY, 175(1), 139-146, JUL 1 2005
  60. Vascular closure staples for portal vein reconstruction in living-donor liver transplantation, AMERICAN JOURNAL OF SURGERY, 190(1), 65-68, JUL 2005
  61. Pseudolymphoma of the liver: a case report and literature review., SURGICAL CASE REPORTS, 1(107), 2015
  62. A case of biliary cystic tumor with repeated hemobilia, SURGICAL CASE REPORTS, 1(34), 2015
  63. MELD and Child-Pugh Scores Are Related to Immune Status of Intrahepatic Natural Killer Cells in Liver Transplant Candidates, TRANSPLANTATION PROCEEDINGS, 49(1), 98-101, 2017
  64. ABO-blood type incompatible living donor liver transplantation in a patient with Budd-Chiari Syndrome secondary to essential thrombocythemia, HEPATOLOGY RESEARCH, 39(5), 520-524, 2009
  65. ABO-blood type incompatible living donor liver transplantation in a patient with Budd-Chiari Syndrome secondary to essential thrombocythemia., Hepatology research : the official journal of the Japan Society of Hepatology, 39(5), 2009
  66. Vascular closure staples for portal vein reconstruction in living-donor liver transplantation., American journal of surgery, 190(1), 2005
  67. Pseudolymphoma of the liver: a case report and literature review, SURGICAL CASE REPORTS, 1(1), 107
  68. A case of biliary cystic tumor with repeated hemobilia, SURGICAL CASE REPORTS, 1(1), 34
  69. Efficacy and Feasibility of Salvage Living Donor Liver Transplantation after Initial Liver Resection in Patients with Hepatocellular Carcinoma, Digestive Surgery, 33(1), 8-14
  70. Acute Graft Rejection and Formation of De Novo Donor-Specific Antibodies Triggered by Low Cyclosporine Levels and Interferon Therapy for Recurrent Hepatitis C Infection After Liver Transplantation: A Case Report., TRANSPLANTATION PROCEEDINGS, 1634-1638, 2017
  71. Aggressive angiomyxoma of the liver: a case report and literature review., SURGICAL CASE REPORTS, 3(1), 92, 2017
  72. Effect of Fc-gamma Receptor Polymorphism on Rituximab-Mediated B Cell Depletion in ABO-Incompatible Adult Living Donor Liver Transplantation., TRANSPLANTATION DIRECT, 2017
  73. Perforation of the gallbladder in a patient with acute cytomegalovirus cholecystitis shortly following renal transplantation., TRANSPLANT INFECUIOUS DISEASE, 2017
  74. Prediction of recurrence following hepatectomy in patients with hepatitis C virus infection-related hepatocellular carcinoma who achieved a sustained virological response., HEPATOLOGY RESEARCH, 2017
  75. Aggressive angiomyxoma of the liver: a case report and literature review, SURGICAL CASE REPORTS, 3, 20170823
  76. Acute Graft Rejection and Formation of De Novo Donor-Specific Antibodies Triggered by Low Cyclosporine Levels and Interferon Therapy for Recurrent Hepatitis C Infection After Liver Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 49(7), 1634-1638, 201709
  77. Prediction of recurrence following hepatectomy in patients with hepatitis C virus infection-related hepatocellular carcinoma who achieved a sustained virological response, HEPATOLOGY RESEARCH, 47(11), 1186-1195, 201710
  78. Perforation of the gallbladder in a patient with acute cytomegalovirus cholecystitis shortly following renal transplantation, TRANSPLANT INFECTIOUS DISEASE, 19(5), 201710
  79. Perioperative management with phosphodiesterase type 5 inhibitor and prostaglandin E1 for moderate portopulmonary hypertension following adult-to-adult living-donor liver transplantation: a case report, SURGICAL CASE REPORTS, 4, FEB 7 2018
  80. Utility of hepatobiliary scintigraphy for recurrent reflux cholangitis following choledochojejunostomy: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 42, 104-108, 2018
  81. A case report on the successful perioperative management of hepatectomy for hepatocellular carcinoma in a patient with von Willebrand disease, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 44, 131-134, 2018
  82. Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution, SURGERY, 164(2), 219-226, AUG 2018
  83. Intraoperative assessment of tissue oxygen saturation of the remnant stomach by near-infrared spectroscopy in two cases of pancreatectomy following gastrectomy., International journal of surgery case reports, 22, 2016
  84. Stepwise approach to curative surgery using percutaneous transhepatic cholangiodrainage and portal vein embolization for severe bile duct injury during laparoscopic cholecystectomy: a case report., Surgical case reports, 2(1), 2016
  85. Different sensitivity of rituximab-treatment to B-cells between ABO-incompatible kidney and liver transplantation., Human immunology, 77(6), 2016
  86. Central bisectionectomy for hepatocellular carcinoma in a patient with indocyanine green excretory defect associated with reduced expression of the liver transporter., Surgical case reports, 2(1), 2016
  87. Intrahepatic cholangiocarcinoma coinciding with a liver metastasis from a rectal carcinoma: a case report., Surgical case reports, 2(1), 2016
  88. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients., International journal of surgery (London, England), 36(Pt A), 2016
  89. Elective laparoscopic deroofing to treat the spontaneous rupture of a large simple liver cyst: a case report., Surgical case reports, 2(1), 2016
  90. Fc-gamma receptor 3A polymorphism predicts the incidence of urinary tract infection in kidney-transplant recipients., Human immunology, 78(4), 2017
  91. Prediction of recurrence following hepatectomy in patients with hepatitis C virus infection-related hepatocellular carcinoma who achieved a sustained virological response., Hepatology research : the official journal of the Japan Society of Hepatology, 47(11), 2017
  92. Predictive Independent Factors for Extrahepatic Metastasis of Hepatocellular Carcinoma Following Curative Hepatectomy., Anticancer research, 37(5), 2017
  93. Significance of the Glasgow Prognostic Score for patients with colorectal liver metastasis., International journal of surgery (London, England), 42, 2017
  94. Biliary-duodenal anastomosis using magnetic compression following massive resection of small intestine due to strangulated ileus after living donor liver transplantation: a case report., Surgical case reports, 3(1), 2017
  95. Perforation of the gallbladder in a patient with acute cytomegalovirus cholecystitis shortly following renal transplantation., Transplant infectious disease : an official journal of the Transplantation Society, 19(5), 2017
  96. Effect of Fc-γ Receptor Polymorphism on Rituximab-Mediated B Cell Depletion in ABO-Incompatible Adult Living Donor Liver Transplantation., Transplantation direct, 3(6), 2017
  97. Aggressive angiomyxoma of the liver: a case report and literature review., Surgical case reports, 3(1), 2017
  98. Utility of hepatobiliary scintigraphy for recurrent reflux cholangitis following choledochojejunostomy: A case report., International journal of surgery case reports, 42, 2018
  99. Perioperative management with phosphodiesterase type 5 inhibitor and prostaglandin E1 for moderate portopulmonary hypertension following adult-to-adult living-donor liver transplantation: a case report., Surgical case reports, 4(1), 2018
  100. A case report on the successful perioperative management of hepatectomy for hepatocellular carcinoma in a patient with von Willebrand disease., International journal of surgery case reports, 44, 2018
  101. Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution., Surgery, 164(2), 2018
  102. Impact of Abdominal Aortic Calcification among Liver Transplant Recipients: A Retrospective Study., Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2018
  103. Independent risk factors that predict bile leakage after hepatectomy for hepatocellular carcinoma: Cohort study., International journal of surgery (London, England), 57, 2018
  104. Independent risk factors that predict bile leakage after hepatectomy for hepatocellular carcinoma: Cohort study, INTERNATIONAL JOURNAL OF SURGERY, 57, 1-7, SEP 2018
  105. Impact of Abdominal Aortic Calcification Among Liver Transplantation Recipients, LIVER TRANSPLANTATION, 25(1), 79-87, 201901
  106. A rare case of transient left ventricular apical ballooning syndrome following living donor liver transplantation: A case report and literature review, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 55, 218-222, 2019
  107. Risk Factors for Refractory Ascites After Living Donor Liver Transplant, TRANSPLANTATION PROCEEDINGS, 51(5), 1516-1519, 201906
  108. Simultaneous Liver-Kidney Transplantation in Patient with a History of Heparin-Induced Thrombocytopenia: A Case Report and Literature Review, AMERICAN JOURNAL OF CASE REPORTS, 20, 980-987, 20190709
  109. Deficiency of N-glycolylneuraminic acid and Galα1-3Galβ1-4GlcNAc epitopes in xenogeneic cells attenuates cytotoxicity of human natural antibodies., Xenotransplantation, 17(6)
  110. Determination of the precursor frequency and the reaction intensity of xenoreactive human T lymphocytes., Xenotransplantation, 17(3)
  111. Immunological property of antibodies against N-glycolylneuraminic acid epitopes in cytidine monophospho-N-acetylneuraminic acid hydroxylase-deficient mice., Journal of immunology (Baltimore, Md. : 1950), 184(6), 2010
  112. Antibody- and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells., Xenotransplantation, 12(3), 2005
  113. Liver sinusoidal endothelial cells tolerize T cells across MHC barriers in mice., Journal of immunology (Baltimore, Md. : 1950), 175(1), 2005
  114. Liver sinusoidal endothelial cells that endocytose allogeneic cells suppress T cells with indirect allospecificity., Journal of immunology (Baltimore, Md. : 1950), 177(6), 2006
  115. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages., Proceedings of the National Academy of Sciences of the United States of America, 104(12), 2007
  116. Possible therapeutic effect of lipid supplementation on neurological complications in liver transplant recipients., Transplant international : official journal of the European Society for Organ Transplantation, 20(7), 2007
  117. Microsurgical hepatic artery reconstruction during living-donor liver transplantation by using head-mounted surgical binocular system., Transplant international : official journal of the European Society for Organ Transplantation, 20(11), 2007
  118. The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation., Blood, 110(13), 2007
  119. Significant correlation between spleen volume and thrombocytopenia in liver transplant patients: a concept for predicting persistent thrombocytopenia., Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 15(2), 2009
  120. Successful hepatitis B vaccination in liver transplant recipients with donor-specific hyporesponsiveness., Transplant international : official journal of the European Society for Organ Transplantation, 22(8), 2009
  121. Evidence for the immunosuppressive potential of calcineurin inhibitor-sparing regimens in liver transplant recipients with impaired renal function., Journal of transplantation, 2011, 2011
  122. Impact of adjuvant immunotherapy using liver allograft-derived lymphocytes on bacteremia in living-donor liver transplantation., Transplantation, 92(5), 2011
  123. Safety and feasibility of diet-treated donors with steatotic livers at the initial consultation for living-donor liver transplantation., Transplantation, 93(10), 2012
  124. Incidental renal cell carcinoma presenting in a renal transplant recipient with autosomal dominant polycystic kidney disease: a case report., Journal of medical case reports, 6, 2012
  125. Surgical treatment for portosystemic encephalopathy in patients with liver cirrhosis: Occlusion of portosystemic shunt in combination with splenectomy., Hepatology research : the official journal of the Japan Society of Hepatology, 43(3), 2013
  126. Controlling the bleeding of jejunal varices formed at the site of choledochojejunostomy: report of 2 cases and a review of the literature., Surgery today, 43(5), 2013
  127. Expression of recipient CD47 on rat insulinoma cell xenografts prevents macrophage-mediated rejection through SIRPα inhibitory signaling in mice., PloS one, 8(3), 2013
  128. Attenuation of portal hypertension by continuous portal infusion of PGE1 and immunologic impact in adult-to-adult living-donor liver transplantation., Transplantation, 95(12), 2013
  129. Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation., Hepatology research : the official journal of the Japan Society of Hepatology, 44(12), 2014
  130. Pancreaticoduodenectomy with preservation of gastric tube blood flow after esophagectomy: Report of a case., International journal of surgery case reports, 5(10), 2014
  131. Successful resolution of very severe hepatopulmonary syndrome following adult-to-adult living donor liver transplantation: Report of two cases., Hepatology research : the official journal of the Japan Society of Hepatology, 45(9), 2015
  132. Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient., Hepatology research : the official journal of the Japan Society of Hepatology, 45(10), 2015
  133. Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation., Hepatology research : the official journal of the Japan Society of Hepatology, 46(7), 2016
  134. Three patients treated with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation: Case report., Hepatology research : the official journal of the Japan Society of Hepatology, 46(7), 2016
  135. Efficacy and Feasibility of Salvage Living Donor Liver Transplantation after Initial Liver Resection in Patients with Hepatocellular Carcinoma., Digestive surgery, 33(1), 2016
  136. Inflammatory pseudotumor of the liver occurring during the course of hepatitis C virus-related hepatocellular carcinoma treatment: A case report., International journal of surgery case reports, 20, 2016
  137. A case of biliary cystic tumor with repeated hemobilia., Surgical case reports, 1(1), 2015
  138. Pseudolymphoma of the liver: a case report and literature review., Surgical case reports, 1(1), 2015
  139. A Phased Desensitization Protocol With Rituximab and Bortezomib for Highly Sensitized Kidney Transplant Candidates., Transplantation direct, 1(5), 2015
  140. Alcohol Use Disorders Identification Test-consumption Predicts the Risk of Excessive Alcohol Consumption After Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 51(6), 1934-1938, 2019
  141. Hepatic epithelioid hemangioendothelioma successfully treated with living donor liver transplantation: A case report and literature review, CLINICAL CASE REPORTS, 8(1), 108-115, 202001
  142. Successful Treatment of Chronic Myeloid Leukemia With Dasatinib After Kidney Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 52(2), 600-603, 202003
  143. A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis in Heart and Kidney Transplant Recipients in Japan, TRANSPLANTATION, 104(2), 437-444, 202002

Invited Lecture, Oral Presentation, Poster Presentation

  1. Effect of desensitization with rituximab on anti-donor T-cell responses in HLA-sensitized liver transplant recipients, Ide.K, Tanaka.Y, Tahara.H, Ohira.M, Shimizu.S, Ohdan.H, Asian Transplantation Week 2017(ATW 2017), 2017/10/18, Without Invitation, Korea
  2. Current status of desensitization protocol for highly HLA-sensitized kidney transplant candidates, Kentaro Ide, Hiroyuki Tahara, Asuka Tanaka, Shuji Akimoto, Sapana Verma, Lalit Kumar Das, Seiichi Shimizu, Masahiro Ohira, Kohei Ishiyama, Yuka Tanaka, Hideki Ohdan, 2017/02/15, Without Invitation
  3. A PHASED DESENSITIZATION PROTOCOL WITH RITUXIMAB AND BORTEZOMIB FOR HIGHLY HLA-SENSITIZED KIDNEY TRANSPLANT CANDIDATES, KENTARO IDE, CONGRESS OF THE ASIAN SOCIETY OF TRANSPLANTATION 2015, 2015/08/25, Without Invitation, Singapore
  4. Assessment using a novel predictive value and treatment for steroid-resistant acute cellular rejection after liver transplantation, Tahara H, Ishiyama K, Ide K, Tanaka Y, Ohira M, Tanimine N, Shimizu S, Kobayashi T, Ohdan H, Transplantation Science Symposium Asian Regional Meeting 2016, 2016/04/08, Without Invitation
  5. Significant association of Innate Immune Related Genes Polymorphism on Infectious Complications Following Early Post Renal Transplantation Phase., Das Lalit Kumar K.Ide, Y.Tanaka, S.Shimizu, N.Tanimine, S.Verma, H.Ohdan, American Transplant Congress 2016, 2016/06/11, Without Invitation
  6. Immunotherapy using donor liver NK cells for preventing severe infection after liver transplantation, 2016/07/13, Without Invitation
  7. A novel paradigm to treat CNI-resistant AMR induced by bacterial pathogen via TLR pathway in B cells, 2016/07/13, Without Invitation
  8. Cotransplantation of preactivated mesenchymal stem cells inhibits liver natural killer cell–induced islet graft injury during instant blood-mediated inflammatory reaction after syngeneic intraportal islet transplantation, Ishida N Ohdan H, Ishiyama K, Saeki Y, Tanaka Y, Tahara H, Verma S, Saparbay D, Sasaki Y, Onoe T, Ohira M, Yano T, Yanagawa S, Taguchi K, Piao J, Tanaka A, Ide K, Shimizu S, Das L K, Nakano R., 26th International Congress of the Transplantation Society, Without Invitation
  9. Different sensitivity of rituximab-treatment to B-cells between ABO-incompatible kidney and liver transplantation., Tanaka A Morimoto H, IdeK, Tanaka Y, Ishiyama K, Ohira M, Tahara H, Shimizu S, Saeki Y, Sakai H, Tano T, Ishida N, Yanagawa S, Tagushi K, Nakano R, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08/18, Without Invitation
  10. Comparison of anti-donor immune response in recipients after kidney and pancreas-kidney transplantation, Kohei Ishiyama Nobuki Ishida, Kentaro Ide, Yuka Tanaka, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10/27, Without Invitation
  11. The 3D Printing Liver Model Contributes Navigation of Anatomical Hepatic Resection, Kuroda S, Kobayashi T, Ishiyama K, Ide K, Ohira M, Tahara H, Shimizu S, Nikawa H, Ohdan H, 2017/06, Without Invitation
  12. Prognosis after liver resection for intermediate stage hepatocellular carcinoma, Okimoto.S, Kobayashi T, Kudora S, Ishiyama K, Ide K, Ohira M, Tahara H, Shimizu S, Ohdan H, 2017/06, Without Invitation
  13. Anatomical hepatectomy with the midline incision for right-sided liver tumors, Kobayashi T, Sho Okimoto, Shintaro Kuroda,Michinori Hamaoka,Seiichi Shimizu,Hiroyuki Tahara,Masahiro Ohira,Kentaro Ide,Kohei Ishiyama,Hideki Ohdan, 2017/06, Without Invitation
  14. Fcg receptor polymorphism influences the effect of rituximab on B-cell depletion in ABO-incompatible adult living donor liver transplantation, Sakai H, Yuka Tanaka, Seiichi Shimizu, Kentaro Ide, Kohei Ishiyama, Takashi Onoe, Masahiro Ohira, Hiroyuki Tahara, Tsuyoshi Kobayashi and Hideki Ohdan, 2017/06, Without Invitation
  15. Approaches to improve pancreas transplant outcome at Hiroshima University, Kohei Ishiyama, Hiroyuki Tahara, Masahiro Ohira, Kentaro Ide, Tsuyoshi Kobayashi, Yuka Tanaka, Hideki Ohdan, 2017/06, Without Invitation
  16. The management for portal vein thrombosis stenosis in liver transplantation, Seiichi Shimizu, Takashi Onoe, Hirotaka Tashiro, Kohei Ishiyama, Kentaro Ide, Masahiro Ohira, Hiroyuki Tahara, Tsuyoshi Kobayashi, Shintaro Kuroda, and Hideki Ohdan, 2017/06, Without Invitation
  17. Evaluation of Immunological States of Patients with Cytomegalovirus Infection After Kidney Transplantation, Tanaka A, Kentaro Ide, Yuka Tanaka, Kohei Ishiyama, Masahiro Ohira, Hiroyuki Tahara, Seiichi Shimizu, Das Lalit Kumar and Hideki Ohdan, American Transplant Congress 2017, 2017/04, Without Invitation
  18. B-cell depletion with rituximab exacerbates anti-donor CD4+ T-Cell responses in patients with donor-specific anti-human leukocyte antigen antibodies, Kentaro Ide, Yuka Tanaka, Hiroyuki Tahara, Masahiro Ohira, Seiichi Shimizu, Asuka Tanaka, Hideki Ohdan, 27th International Congress of the Transplantation Society, 2018/06, Without Invitation

External Funds

Acceptance Results of Competitive Funds

  1. KAKENHI(Grant-in-Aid for Scientific Research (C)), 2017, 2019
  2. 2016
  3. 2016
  4. KAKENHI, 2014, 2016
  5. 2013, 2013
  6. KAKENHI, The conquest of anti NeuGc antibody mediated xenogeneic islet rejection through CD47-SIRPα signaling., 2011, 2012
  7. KAKENHI, The CD47-SIRPa signaling blockade accelerates macrophage phagocytic activity against cancer cells, 2011, 2013
  8. 2009, 2010
  9. KAKENHI, 2009, 2010
  10. KAKENHI, Strategy of macrophage-mediated xenograft rejection through inhibitory signaling to SIRP., 2008, 2009
  11. KAKENHI, Inhibition of xeno-antigen reactive T cells and B cells by regulation of CD47-SIRP signaling, 2008, 2010
  12. 2008, 2008
  13. 2005, 2005